View of Molecular Docking and QSAR Studies of Pyrimidine Analogues as BCL2 Proteins Inhibitors and EGFR Tyrosine Kinase Inhibitors

Return to Article Details Molecular Docking and QSAR Studies of Pyrimidine Analogues as BCL2 Proteins Inhibitors and EGFR Tyrosine Kinase Inhibitors Download Download PDF